|
Index of reports
> Cases with Oedema Peripheral (122)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) where reactions include oedema peripheral. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 122 Next >>
Possible Magnevist side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: 56 year old male
Reactions: Cellulitis, Oedema Peripheral, Inflammation
Drug(s) suspected as cause:
Magnevist
Possible Magnevist side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)
Reactions: Wheelchair User, Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Paraesthesia, Skin Tightness, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia, Extremity Contracture, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-01-01
End date: 2005-01-01
Magnevist
Dosage: 15 ml (daily dose), once,
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-08-11
End date: 2000-08-11
Magnevist
Dosage: 15 ml (daily dose), once,
Start date: 2001-07-27
End date: 2001-07-27
Other drugs received by patient: Nephrocaps; Phoslo; Metronidazole; Renagel; Coreg; Prinivil; Atenolol; Warfarin Sodium; Darvocet; Vancocin Hydrochloride; Sodium Bicarbonate; Iron [iron]; Amoxicillin; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Hydrocodone Bitartrate and Acetaminophen; Tylenol with Codein #3; Phoslo; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Aspirin; Vitamin B6; Coreg; Epogen; Diltiazem; Plendil; Plendil; Lisinopril
Possible Magnevist side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: 58 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Skin Exfoliation, Quality of Life Decreased, Pain, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Injury, Fibrosis, Blood Creatinine Increased, Extremity Contracture, Blister, Muscle Contracture, Rash Papular, Contrast Media Reaction, Skin Disorder, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Deformity, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Burning Sensation, Renal Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Other drugs received by patient: Calcium Acetate; Irbesartan; Clonidine; Hydralazine HCL; Visipaque; Visipaque; Glipizide; Ferrous Sulfate TAB; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Metoprolol Tartrate; Sevelamer Hydrochloride; Terazosin Hydrochloride; Dovonex; Contrast Media; Contrast Media; Synthroid; Aspirin; Felodipine; Contrast Media; Lasix; Omniscan; Folic Acid; Iron; Insulin; EPO
Possible Magnevist side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient: 69 year old male
Reactions: Subcutaneous Nodule, Pain in Extremity, Skin Exfoliation, Abasia, Muscular Weakness, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Muscle Tightness, Skin Fissures, Skin Plaque, Hand Deformity, Skin Discolouration, Oedema Peripheral, Nodule, Injury, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-04-21
End date: 2004-04-21
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2004-04-13
End date: 2004-04-13
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Spinal
Start date: 2005-02-22
End date: 2005-02-22
Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Minoxidil; Zemplar; Doxazosin Mesylate; Sensipar; Folic Acid; Isosorbide; Allopurinol; Oxycontin; Epogen; Crestor; Phoslo
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Magnevist side effects in 49 year old male
Reported by a lawyer from United States on 2012-08-02
Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Start date: 2004-05-19
End date: 2004-05-19
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-19
End date: 2006-05-19
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-13
End date: 2006-10-13
Magnevist
Dosage: 20 ml, unk
Start date: 2006-10-17
End date: 2006-10-17
Multihance
Indication: Product Used FOR Unknown Indication
Omniscan
Omniscan
Dosage: 50 ml omniscan+co2
Indication: Fistulogram
Start date: 2006-08-04
End date: 2006-08-04
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-05
End date: 2006-08-05
Optimark
Indication: Product Used FOR Unknown Indication
Prohance
Indication: Computerised Tomogram Head
Start date: 2004-05-19
End date: 2004-05-19
Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine
Possible Magnevist side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 56 year old female
Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Magnevist
Indication: Renal Mass
Optimark
Indication: Muscular Weakness
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol
Possible Magnevist side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Indication: Renal Mass
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Optimark
Indication: Headache
Optimark
Indication: Disorientation
Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]
Possible Magnevist side effects in 49 year old female
Reported by a consumer/non-health professional from United States on 2012-07-18
Patient: 49 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Skin Wrinkling, Joint Stiffness, Oedema Peripheral, Melanocytic Naevus, Fibrosis, Arthrofibrosis, General Physical Health Deterioration, Hypoaesthesia, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Paraesthesia, Skin Tightness, Scar, Abasia, Pain, Joint Contracture, Skin Hyperpigmentation, Muscle Tightness, Tendon Pain, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Injury, Joint Ankylosis, Extremity Contracture, Myocardial Fibrosis, Dyspnoea, Rash Papular, Musculoskeletal Pain, Skin Disorder, Muscular Weakness, Rash Macular, Pulmonary Fibrosis, Arthralgia, Gait Disturbance, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Start date: 2004-05-20
End date: 2004-05-20
Magnevist
Start date: 1999-11-09
End date: 1999-11-09
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 1997-04-30
End date: 1997-04-30
Magnevist
Start date: 1998-12-31
End date: 1998-12-31
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1996-10-30
End date: 1996-10-30
Magnevist
Start date: 2002-01-30
End date: 2002-01-30
Magnevist
Start date: 2005-01-30
End date: 2005-01-30
Magnevist
Start date: 1997-11-17
End date: 1997-11-17
Magnevist
Dosage: 9.7 ml, once
Start date: 2003-03-20
End date: 2003-03-20
Magnevist
Start date: 2000-11-08
End date: 2000-11-08
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-01-30
End date: 2005-01-30
Omniscan
Start date: 2005-03-20
End date: 2005-03-20
Omniscan
Dosage: unk
Other drugs received by patient: Thyroid Therapy; Ferrous Sulfate TAB; Miacalcin; Cytoxan; Oxandrin; Folic Acid; Procardia; Synthroid; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Advair Diskus 100 / 50; Zemplar; Aranesp; Aleve; Prograf; Epogen; Exforge; Activase; Celebrex; Zestril; Renagel; Metoprolol Succinate; Amigen; Prempro; Rocaltrol; Spironolactone; Demadex; Sensipar; Myfortic; Prednisone; Clonidine; Amlodipine Besylate
Possible Magnevist side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: male
Reactions: Oedema Peripheral, Rash Macular, Rash Pruritic
Drug(s) suspected as cause:
Magnevist
Magnevist
Dosage: 20 ml, once
Indication: Haemochromatosis
Start date: 2012-01-07
End date: 2012-01-07
Possible Magnevist side effects in 69 year old male
Reported by a physician from United States on 2012-07-12
Patient: 69 year old male
Reactions: Subcutaneous Nodule, Skin Exfoliation, Abasia, Skin Hyperpigmentation, Muscle Tightness, Skin Fissures, Hand Deformity, Skin Discolouration, Oedema Peripheral, Nodule, Injury, Pain in Extremity, Muscular Weakness, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Plaque, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-04-21
End date: 2004-04-21
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2004-04-13
End date: 2004-04-13
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Spinal
Start date: 2005-02-22
End date: 2005-02-22
Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Isosorbide; Zemplar; Sensipar; Epogen; Oxycontin; Doxazosin Mesylate; Crestor; Minoxidil; Allopurinol; Phoslo; Folic Acid
Possible Magnevist side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf
Possible Magnevist side effects in 51 year old female
Reported by a lawyer from United States on 2012-07-09
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis Device Insertion
Multihance
Indication: Fistulogram
Multihance
Indication: Venogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Fistulogram
Omniscan
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Venogram
Optimark
Indication: Fistulogram
Prohance
Indication: Venogram
Prohance
Indication: Fistulogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl
Possible Magnevist side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 54 year old male
Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-11-29
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec
Possible Magnevist side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-28
Patient: male, weighing 83.0 kg (182.6 pounds)
Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Magnevist
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-05-18
End date: 1998-05-18
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor
Possible Magnevist side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin
Possible Magnevist side effects in 58 year old female
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, unk
Indication: Imaging Procedure
Start date: 2003-12-20
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-05-26
End date: 2005-05-26
Magnevist
Dosage: 15 ml, unk
Indication: Angiogram
Start date: 2006-05-30
Multihance
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps
Possible Magnevist side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Post Thrombotic Syndrome, Skin Discolouration, Induration, Oedema Peripheral, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Verapamil; Lasix; Coumadin; Clonidine; Epogen; Minoxidil; Albuterol; Calcitriol; Lanoxin; Renagel; Sensipar; Glyburide; Flovent; Insulin; Iron Sulfatethiamin Compound TAB
Possible Magnevist side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Post Thrombotic Syndrome, Oedema Peripheral, Induration, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Albuterol; Minoxidil; Renagel; Insulin; Calcitriol; Lanoxin; Verapamil; Lasix; Epogen; Sensipar; Flovent; Coumadin; Glyburide; Clonidine; Iron Sulfatethiamin Compound TAB
Possible Magnevist side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 54 year old male
Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Possible Magnevist side effects in 14 year old male
Reported by a physician from Japan on 2012-06-08
Patient: 14 year old male, weighing 48.0 kg (105.6 pounds)
Reactions: Pruritus, Hyperkeratosis, Hyperthermia, Joint Contracture, Pyrexia, Scleroderma, Erythema, Oedema Peripheral, White Blood Cell Count Increased, Pain in Extremity, Rash Papular, Muscle Contracture, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Collagen Disorder, Hypoproteinaemia, Grip Strength Decreased, Inflammation
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Magnevist
Dosage: 10 ml (daily dose), once, intravenous
Start date: 2004-12-17
End date: 2004-12-17
Magnevist
Dosage: 10 ml (daily dose), once, intravenous
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-24
End date: 2004-07-24
Omniscan
Dosage: 10 ml (daily dose), once, intravenous
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-12-28
End date: 2006-12-28
Omniscan
Dosage: 10 ml (daily dose), once, intravenous
Start date: 2007-01-12
End date: 2007-01-12
Omniscan
Dosage: 10 ml (daily dose), once, intravenous
Indication: Glaucoma
Start date: 2006-09-04
End date: 2006-09-04
Other drugs received by patient: Calcium Carbonate; Calcium Carbonate; Dexamethasone; Allopurinol; Amlodipine; Ferrous Citrate
Possible Magnevist side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot
Possible Magnevist side effects in 58 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: 58 year old , weighing 95.2 kg (209.5 pounds)
Reactions: Arthralgia, Pain in Extremity, Thrombophlebitis Superficial, Induration, Oedema Peripheral, Injection Site Pain, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Magnevist
Other drugs received by patient: Lisinopril; Evista; Spironeactive; Xanax; Lipitor
Possible Magnevist side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela
Possible Magnevist side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax
Possible Magnevist side effects in 51 year old female
Reported by a lawyer from United States on 2012-05-31
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Indication: Dialysis Device Insertion
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Multihance
Indication: Fistulogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Venogram
Omniscan
Indication: Venogram
Omniscan
Indication: Fistulogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Fistulogram
Prohance
Indication: Fistulogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Venogram
Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate
Possible Magnevist side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 56 year old female
Reactions: Joint Contracture, Pain, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Depression, Injury, Extremity Contracture, Muscular Weakness, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Disorientation
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Headache
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Renvela; Prednisone; Lantus; Sensipar; Atenolol; Prograf
Possible Magnevist side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Skin Hyperpigmentation, Ephelides, Joint Stiffness, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Depression, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, Muscular Weakness, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Rash, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-05-21
End date: 2004-05-21
Magnevist
Indication: Renal Mass
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Lantus; Sensipar; Phoslo; Procrit; Renvela; Prograf; Atenolol; Slow Release Iron; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone TAB
Possible Magnevist side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 62 year old male, weighing 124.0 kg (272.8 pounds)
Reactions: Pruritus, Hyperkeratosis, Pain, Erythema, Rash Pruritic, Skin Ulcer, Skin Lesion, Oedema Peripheral, Skin Atrophy, Pain in Extremity, Pain of Skin, Skin Disorder, Rash, Hypoaesthesia, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Plaque, Burning Sensation, Emotional Distress, Anxiety, Exfoliative Rash, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-01-17
End date: 2006-01-17
Omniscan
Dosage: 40 ml, then 50 ml
Indication: Angiogram
Start date: 2004-11-09
End date: 2004-11-09
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Gabapentin; Renagel; Hydrochlorothiazide; Dalteparin Sodium; Magnesium; Epogen; Carvedilol; Atenolol; Lyrica; Calcium; Benicar; Folic Acid; Simvastatin; Hydralazine HCL; Aranesp; Mirtazapine; Codeine Sulfate; Norvasc; Darvocet; Renagel; Metoprolol; Furosemide; Renagel; Doxazosin Mesylate
Possible Magnevist side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-17
End date: 2006-03-17
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: unk, once
Start date: 2005-10-18
End date: 2005-10-18
Omniscan
Dosage: unk, once
Start date: 2005-10-21
End date: 2005-10-21
Omniscan
Dosage: unk, once
Start date: 2005-10-01
End date: 2005-10-01
Omniscan
Dosage: unk, once
Start date: 2005-09-06
End date: 2005-09-06
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-08
End date: 2005-09-08
Omniscan
Dosage: unk, once
Start date: 2005-09-28
End date: 2005-09-29
Omniscan
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Renal
Start date: 2005-08-25
End date: 2005-08-25
Omniscan
Dosage: unk, once
Indication: Venogram Renal
Start date: 2005-09-01
End date: 2005-09-01
Omniscan
Dosage: unk, once
Indication: Angiogram Peripheral
Start date: 2005-08-30
End date: 2005-08-30
Omniscan
Dosage: unk, once
Start date: 2005-11-03
End date: 2005-11-03
Omniscan
Dosage: unk, once
Start date: 2005-10-03
End date: 2005-10-03
Omniscan
Dosage: unk
Optimark
Dosage: 19 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-04-20
End date: 2005-04-20
Optimark
Dosage: 19 ml, once
Start date: 2005-07-05
End date: 2005-07-05
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril
Page 1 Next >>
|
